ERBB2 and breast cancer: Hierarchical clustering of RT-qPCR data of the 9 breast cell lines for EMP markers, inducers and regulators, along with the BC clinically relevant ESR1, PGR and ERBB2 gene products, showed substantial variation across the cell lines and revealed two major branches (Figure 1A).